Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2016, Article ID 1831792, 6 pages
http://dx.doi.org/10.1155/2016/1831792
Case Report

Primary MALT Lymphoma of the Breast Treated with Definitive Radiation

1Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
2Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai Hospital, New York, NY 10029, USA
3Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA

Received 11 February 2016; Revised 14 April 2016; Accepted 17 April 2016

Academic Editor: Gandhi Damaj

Copyright © 2016 Mohammad Hissourou III et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Topalovski, D. Crisan, and J. C. Mattson, “Lymphoma of the breast: a clinicopathologic study of primary and secondary cases,” Archives of Pathology and Laboratory Medicine, vol. 123, no. 12, pp. 1208–1218, 1999. View at Google Scholar · View at Scopus
  2. M. O. Khalil, L. M. Morton, S. S. Devesa et al., “Incidence of marginal zone lymphoma in the United States, 2001–2009 with a focus on primary anatomic site,” British Journal of Haematology, vol. 165, no. 1, pp. 67–77, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J. O. Armitage and D. D. Weisenburger, “New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project,” Journal of Clinical Oncology, vol. 16, no. 8, pp. 2780–2795, 1998. View at Google Scholar · View at Scopus
  4. B. C. Chiu and D. D. Weisenburger, “An update of the epidemiology of non-Hodgkin's lymphoma,” Clinical Lymphoma, vol. 4, no. 3, pp. 161–168, 2003. View at Publisher · View at Google Scholar
  5. K. E. Smedby, E. Baecklund, and J. Askling, “Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics,” Cancer Epidemiology Biomarkers & Prevention, vol. 15, no. 11, pp. 2069–2077, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Parsonnet, S. Hansen, L. Rodriguez et al., “Helicobacter pylori infection and gastric lymphoma,” The New England Journal of Medicine, vol. 330, no. 18, pp. 1267–1271, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. R. J. Bende, F. Van Maldegem, and C. J. M. Van Noesel, “Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas,” Haematologica, vol. 94, no. 8, pp. 1109–1123, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Hyjek and P. G. Isaacson, “Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's Thyroiditis,” Human Pathology, vol. 19, no. 11, pp. 1315–1326, 1988. View at Publisher · View at Google Scholar
  9. M. Nørgaard, A. H. Poulsen, L. Pedersen et al., “Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study,” British Journal of Cancer, vol. 94, no. 9, pp. 1339–1341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. K. H. Mildon, P. Ansell, E. Roman, and E. V. Kane, “Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case-control study,” Cancer Causes & Control, vol. 21, no. 12, pp. 2079–2083, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Fernandez, S. Gallus, C. Bosetti, S. Franceschi, E. Negri, and C. La Vecchia, “Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies,” International Journal of Cancer, vol. 105, no. 3, pp. 408–412, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. M. M. Liu, C. Albanese, C. M. Anderson et al., “Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression,” The Journal of Biological Chemistry, vol. 277, no. 27, pp. 24353–24360, 2002. View at Publisher · View at Google Scholar
  13. D. Gupta, V. Shidham, V. Zemba-Palko, and A. Keshgegian, “Primary bilateral mucosa-associated lymphoid tissue lymphoma of the breast with atypical ductal hyperplasia and localized amyloidosis. A case report and review of the literature,” Archives of Pathology and Laboratory Medicine, vol. 124, no. 8, pp. 1233–1236, 2000. View at Google Scholar · View at Scopus
  14. P. Batstone, L. Forsyth, and J. R. Goodlad, “Cytogenetic evidence for the origin of neoplastic cells in CD5-positive marginal zone B-cell lymphoma,” Human Pathology, vol. 34, no. 10, pp. 1065–1067, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Ghetu, V. Membrez, A. Bregy et al., “Expect the unexpected: primary breast MALT lymphoma,” Archives of Gynecology and Obstetrics, vol. 284, no. 5, pp. 1323–1324, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. R. W. Tsang, M. K. Gospodarowicz, M. Pintilie et al., “Stage I and II malt lymphoma: results of treatment with radiotherapy,” International Journal of Radiation Oncology Biology Physics, vol. 50, no. 5, pp. 1258–1264, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Wright, H. Maclean, and J. Ironside, “Metachronous lymphoma of the breast and conjunctiva,” The British Journal of Ophthalmology, vol. 80, no. 6, article 574, 1996. View at Google Scholar · View at Scopus
  18. B. Zobolas, G. H. Sakorafas, I. Kourakli, and A. G. Tsiotou, “Bilateral, primary, low-grade, diffuse B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) of the breast,” Breast Journal, vol. 8, no. 6, p. 382, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. E. M. Bailey, J. A. Ferry, N. L. Harris, M. C. Mihm Jr., J. O. Jacobson, and L. M. Duncan, “Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients,” The American Journal of Surgical Pathology, vol. 20, no. 8, pp. 1011–1023, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. R. R. Rajendran, J. P. Palazzo, G. F. Schwartz, J. H. Glick, and L. J. Solin, “Primary mucosa-associated lymphoid tissue lymphoma of the breast,” Clinical Breast Cancer, vol. 8, no. 2, pp. 187–188, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Matsuda, T. Watanabe, Y. Enomoto, Y. Takatsuka, Y. Miyoshi, and S. Hirota, “Spontaneous regression of primary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) colliding with invasive ductal carcinoma of the breast: a case report,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 10, pp. 7020–7027, 2014. View at Google Scholar · View at Scopus
  22. S. H. Arslan, U. Uyeturk, E. Tekgunduz et al., “Primary breast Mucosa-Associated Lymphoid Tissue (MALT) lymphoma transformation to diffuse large B-cell lymphoma: a case report,” Turkish Journal of Hematology, vol. 29, no. 3, pp. 274–277, 2012. View at Publisher · View at Google Scholar
  23. C. W. Michael, P. H. Richardson, and C. W. Boudreaux, “Pulmonary lymphoma of the mucosa-associated lymphoid tissue type: report of a case with cytological, histological, immunophenotypical correlation, and review of the literature,” Annals of Diagnostic Pathology, vol. 9, no. 3, pp. 148–152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Nassif and M. Ozdemirli, “EBV-positive low-grade marginal zone lymphoma in the breast with massive amyloid deposition arising in a heart transplant patient: a report of an unusual case,” Pediatric Transplantation, vol. 17, no. 6, pp. E141–E145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Huber, M. Vesely, M. Medl, and H. Czembirek, “Low-grade mucosa-associated lymphoma of the breast: radiological-pathological correlation,” European Radiology, vol. 12, no. 5, pp. 1093–1096, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Julen, I. Dellacasa, M. F. Pelte et al., “Primary breast lymphomas,” Rare Tumors, vol. 1, no. 1, article e14, 2009. View at Publisher · View at Google Scholar
  27. M. Kambouchner, P. Godmer, L. Guillevin, M. Raphaël, D. Droz, and A. Martin, “Low grade marginal zone B cell lymphoma of the breast associated with localised amyloidosis and corpora amylacea in a woman with long standing primary Sjögren's syndrome,” Journal of Clinical Pathology, vol. 56, no. 1, pp. 74–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. D.-H. Kim, J. Y. Jeong, S.-W. Lee, J. Lee, and B.-C. Ahn, “18F-FDG PET/CT finding of bilateral primary breast mucosa-associated lymphoid tissue lymphoma,” Clinical Nuclear Medicine, vol. 40, no. 2, pp. e148–e149, 2015. View at Publisher · View at Google Scholar · View at Scopus
  29. M. J. J. Kuper-Hommel, L. W. Vrints, J. W. W. Coebergh, and G. Vreugdenhil, “High grade MALT-lymphoma of the breast,” Netherlands Journal of Medicine, vol. 54, no. 6, pp. 235–238, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. A. R. Mattia, J. A. Ferry, and N. L. Harris, “Breast lymphoma: a B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue,” American Journal of Surgical Pathology, vol. 17, no. 6, pp. 574–587, 1993. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Raderer, S. Wöhrer, R. Bartsch et al., “Phase II study of oxaliplatin for treatment of patients with mucosa-associated lymphoid tissue lymphoma,” Journal of Clinical Oncology, vol. 23, no. 33, pp. 8442–8446, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. S. M. Said, C. Reynolds, R. E. Jimenez et al., “Amyloidosis of the breast: predominantly AL type and over half have concurrent breast hematologic disorders,” Modern Pathology, vol. 26, no. 2, pp. 232–238, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Taeda, N. Ariga, K. Okamura et al., “Primary breast mucosa-associated lymphoid tissue (MALT) lymphoma with high-grade transformation evidenced by prominent lymphoepithelial lesions,” Breast Cancer, vol. 13, no. 3, pp. 322–327, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. J. S. Welsh, A. Howard, H. Y. Hong, D. Lucas, T. Ho, and D. J. Reding, “Synchronous bilateral breast mucosa-associated lymphoid tissue lymphomas addressed with primary radiation therapy,” American Journal of Clinical Oncology, vol. 29, no. 6, pp. 634–635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. N. S. Anavekar, W. M. Rozen, K. Rowe, and C. Murphy, “Synchronous carcinoma and lymphoma of the breast,” Clinical Breast Cancer, vol. 8, no. 3, pp. 281–284, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. M. J. J. Kuper-Hommel, S. Snijder, M. L. G. Janssen-Heijnen et al., “Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews,” Annals of Hematology, vol. 82, no. 7, pp. 397–404, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Bertoni and E. Zucca, “State-of-the-art therapeutics: marginal-zone lymphoma,” Journal of Clinical Oncology, vol. 23, no. 26, pp. 6415–6420, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Zucca, A. Conconi, E. Pedrinis et al., “Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue,” Blood, vol. 101, no. 7, pp. 2489–2495, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. Domchek, J. L. Hecht, M. D. Fleming, G. S. Pinkus, and G. P. Canellos, “Lymphomas of the breast: primary and secondary involvement,” Cancer, vol. 94, no. 1, pp. 6–13, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Rock, G. Rangaswamy, S. O'Sullivan, and J. Coffey, “An unusual case of marginal zone B-cell lymphoma arising in the breast—its diagnosis and the role of radiotherapy in its management,” Breast Care, vol. 6, no. 5, pp. 391–393, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. R. W. Tsang, M. K. Gospodarowicz, M. Pintilie et al., “Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome,” Journal of Clinical Oncology, vol. 21, no. 22, pp. 4157–4164, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Yahalom, T. Illidge, L. Specht et al., “Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the international lymphoma radiation oncology group,” International Journal of Radiation Oncology Biology Physics, vol. 92, no. 1, pp. 11–31, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Teckie, S. Qi, S. Lovie et al., “Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent,” International Journal of Radiation Oncology Biology Physics, vol. 92, no. 1, pp. 130–137, 2015. View at Publisher · View at Google Scholar · View at Scopus